Literature DB >> 31929119

Characterizing Enrollment in Observational Studies of Duchenne Muscular Dystrophy by Race and Ethnicity.

Alison M Barnard1, Samuel L Riehl2, Rebecca J Willcocks2, Glenn A Walter1, Amber M Angell3, Krista Vandenborne2.   

Abstract

Observational research benefits from inclusion of diverse cohorts. To characterize racial and ethnic diversity in observational and natural history research studies of Duchenne muscular dystrophy (DMD), highly cited and influential observational studies were identified. Fourteen United States-based articles were included. All studies cited >70% White participants with the majority having few racial minority participants. Enrollment of Black/African American individuals was particularly limited (<5% in all but one study), and Hispanic/Latino participants ranged from 3.3- 26.5% of cohorts. These results suggest a need for effective strategies to recruit, enroll, and retain racially and ethnically diverse populations into observational research in DMD.

Entities:  

Keywords:  Bibliometrics; Healthcare Disparities; Minority Health; Muscular dystrophies; Observational Studies

Mesh:

Year:  2020        PMID: 31929119      PMCID: PMC7493003          DOI: 10.3233/JND-190447

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  41 in total

1.  Palliative care services in families of males with Duchenne muscular dystrophy.

Authors:  Rebeca Arias; Jennifer Andrews; Shree Pandya; Kathleen Pettit; Christina Trout; Susan Apkon; Jane Karwoski; Christopher Cunniff; Dennis Matthews; Timothy Miller; Melinda F Davis; F John Meaney
Journal:  Muscle Nerve       Date:  2011-07       Impact factor: 3.217

2.  Breathe Duchenne: what natural history studies tell us about the progression of pulmonary morbidity in Duchenne muscular dystrophy.

Authors:  Oscar H Mayer; Andrea Aliverti; Thomas Meier
Journal:  Neuromuscul Disord       Date:  2018-08-25       Impact factor: 4.296

3.  The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales.

Authors:  Sarah E Davis; Linda S Hynan; Christine A Limbers; C Mariam Andersen; Medrith C Greene; James W Varni; Susan T Iannaccone
Journal:  J Clin Neuromuscul Dis       Date:  2010-03

4.  Racial differences in factors that influence the willingness to participate in medical research studies.

Authors:  Vickie L Shavers; Charles F Lynch; Leon F Burmeister
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

5.  Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Craig M McDonald; Craig Campbell; Ricardo Erazo Torricelli; Richard S Finkel; Kevin M Flanigan; Nathalie Goemans; Peter Heydemann; Anna Kaminska; Janbernd Kirschner; Francesco Muntoni; Andrés Nascimento Osorio; Ulrike Schara; Thomas Sejersen; Perry B Shieh; H Lee Sweeney; Haluk Topaloglu; Már Tulinius; Juan J Vilchez; Thomas Voit; Brenda Wong; Gary Elfring; Hans Kroger; Xiaohui Luo; Joseph McIntosh; Tuyen Ong; Peter Riebling; Marcio Souza; Robert J Spiegel; Stuart W Peltz; Eugenio Mercuri
Journal:  Lancet       Date:  2017-07-17       Impact factor: 79.321

6.  The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Jay J Han; Diana M Escolar; Julaine M Florence; Tina Duong; Adrienne Arrieta; Paula R Clemens; Eric P Hoffman; Avital Cnaan
Journal:  Muscle Nerve       Date:  2013-05-16       Impact factor: 3.217

7.  Disparities in health care utilization by race among teenagers and young adults with muscular dystrophy.

Authors:  Orgul D Ozturk; Suzanne McDermott; Joshua R Mann; James W Hardin; Julie A Royer; Lijing Ouyang
Journal:  Med Care       Date:  2014-10       Impact factor: 2.983

8.  Lessons learned: Engaging culturally diverse families in neurodevelopmental disorders intervention research.

Authors:  Allison B Ratto; Bruno J Anthony; Cara Pugliese; Rocio Mendez; Jonathan Safer-Lichtenstein; Katerina M Dudley; Nicole F Kahn; Lauren Kenworthy; Matthew Biel; Jillian L Martucci; Laura G Anthony
Journal:  Autism       Date:  2016-06-15

Review 9.  Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups.

Authors:  Billie Bonevski; Madeleine Randell; Chris Paul; Kathy Chapman; Laura Twyman; Jamie Bryant; Irena Brozek; Clare Hughes
Journal:  BMC Med Res Methodol       Date:  2014-03-25       Impact factor: 4.615

10.  Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy.

Authors:  Erika Finanger; Krista Vandenborne; Richard S Finkel; H Lee Sweeney; Gihan Tennekoon; Sabrina Yum; Maria Mancini; Pradeep Bista; Andrew Nichols; Hanlan Liu; Angelika Fretzen; Joanne M Donovan
Journal:  J Neuromuscul Dis       Date:  2019
View more
  1 in total

1.  Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities.

Authors:  Lisa Shea; Jacqueline Pesa; Gabrielle Geonnotti; Valerie Powell; Caryl Kahn; Wesley Peters
Journal:  Health Expect       Date:  2022-06-28       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.